Antipsychotics Increase Type 2 Diabetes Risk 3-Fold
No surprise here!
In a retrospective study of more than 43,000 individuals, children and young people who were prescribed antipsychotics were significantly more likely to develop Type 2 Diabetes within the first year of use.
The study included 28,858 first-time users of antipsychotic medications. All participants were 6 to 24 years of age. Antipsychotic medications used included risperidone, quetiapine, aripiprazole, and olanzapine. Medications also used included mood stabilizers such as lithium, as well as antidepressants, psychostimulants, a-agonists, and benzodiazepines.
These young Antipsychotic users had a 3-fold increased risk of developing Type 2 Diabetes by the end of the study.
Antipsychotics disrupt normal and healthy metabolism, have unhealthy nerve and muscular side effects, and unhealthy cardiovascular side effects.
Antipsychotic medications, including antidepressants, all have very serious unhealthy side effects, including significant weight gain and suicide, and now the development of Type 2 Diabetes. Type 2 Diabetes is a debilitating disease that causes other health problems and lowers the length and quality of life. Type 2 Diabetes requires the frequent use of medications. The other side effects from use of antipschotics also require medications for treatment.
Is your doctor a Quack? Are the physicians, psychologists and school administrators that recommend young people use antipsychotics as a first line of defense sentencing these young people to a lifetime of medications use and ill health? Medications to treat Type 2 Diabetes and the other diseases caused by Diabetes. Medications to treat depression and anxiety. Medications to treat the many other debilitating side effects of these antipsychotics.
If your doctor recommends that either you or your child take antipsychotics (including antidepressants) as the first line of treatement, you may want to ask yourself, “Is my doctor a quack?”. That has become a fair question to ask after several years of numerous studies indicating the lack of effectiveness/benefits in most individuals, and the dangerous side effects.
This study was lead by Alba Morales Pozzo, MD Associate Professor, Department of Pediatrics, Division of Endocrinology and Diabetes, University of Arkansas for Medical Sciences.
More about Ralph Teller
Original copyright 2013